| Drug Name | pegaspargase(Oncaspar®) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
risk of allergic reactions |
| safety communication |
|